The Regents of the University of California, Los Angeles
Welcome,         Profile    Billing    Logout  
 6 Trials 
14 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Irwin, Michael R
NCT04310423: An Inflammatory Challenge Using Endotoxin

Completed
2
20
US
Placebo, Saline (0.9%), Endotoxin, Escherichia coli
University of California, Los Angeles
Alcohol Use Disorder, Inflammatory Response, Craving, Depressed Mood
11/23
11/23
NCT03848715: Sleep and Healthy Aging Research on Depression for Younger Women

Completed
1
40
US
Endotoxin, Placebo
University of California, Los Angeles
Anhedonia, Depression
07/22
07/24
SHARE-D, NCT03256760: Sleep and Healthy Aging Research for Depression () Study

Completed
1
160
US
Endotoxin, Placebo
Michael Irwin, MD
Depression in Old Age
04/24
04/24
ARIA, NCT05363527: Aging and Reward System Response to Inflammation and Anxiety Study

Recruiting
1
40
US
Endotoxin, Placebo
University of California, Los Angeles, National Institute on Aging (NIA)
Anhedonia, Inflammation, Anxiety, Aging, Depression
03/26
03/26
NCT04601961: Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients

Recruiting
N/A
220
RoW
Propofol, Sevoflurane
The University of Hong Kong
Circulating Tumor Cell, Hepatocellular Carcinoma
01/24
03/24
HERO, NCT03345563: Project Health Empowerment & Recovery Outcomes

Completed
N/A
113
US
Body Mind Training (BMT), Body Training (BT):, Usual Care (UC)
Rutgers, The State University of New Jersey, University of California, Los Angeles, University of New Mexico
Prostate Cancer, Bladder Cancer, Kidney Cancer, Colon Cancer, Rectum Cancer, Thyroid Cancer, Lung Cancer, Small Intestine Cancer, Soft Tissue Cancer
03/23
03/23
NCT00690196: Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms

Active, not recruiting
N/A
90
US
Tai Chi Chih, TCC, Cognitive Behavioral Therapy, CBT
Jonsson Comprehensive Cancer Center, National Center for Research Resources (NCRR)
Sleep Disorders, Sleep Initiation and Maintenance Disorders, Dyssomnias, Mental Disorders, Nervous System Diseases
07/25
07/26
AIMS, NCT06639477: Assessing Improvements in Mood and Sleep Trial

Not yet recruiting
N/A
420
US
Treatment As Usual, Active Condition, Active Comparator
University of Pittsburgh, Emory University, University of California, Berkeley, University of California, Los Angeles, Augusta University, National Institutes of Health (NIH), National Institute of Mental Health (NIMH)
Depression, Suicidality, Sleep
08/29
08/30
McMahon, Maureen
SELUNE, NCT04181762 / 2019-003211-57: Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis

Terminated
3
275
Europe, Canada, Japan, US, RoW
secukinumab, AIN457, Placebo
Novartis Pharmaceuticals
Lupus Nephritis
09/23
09/23
SIRIUS-LN, NCT05126277 / 2020-005830-14: Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

Recruiting
3
420
Europe, Canada, US, RoW
ianalumab s.c. q4w, VAY736, ianalumab s.c. q12w, placebo s.c., placebo
Novartis Pharmaceuticals, Novartis Pharma AG
Lupus Nephritis
03/27
07/30
NCT05000216: COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Completed
2
257
US
Moderna mRNA-1273, mRNA-1273 vaccine (Moderna), Moderna COVID-19 Vaccine, SARS-CoV-2 RNA vaccine, COVID-19 vaccine, BNT162b2, mRNA-1273 vaccine (Pfizer/BioNTech), Pfizer-BioNTech COVID-19 vaccine, Ad26.COV2.S, Janssen COVID-19 Vaccine, JNJ-78436735, Continue IS (MMF or MPA), immunosuppressive medication, mycophenolate mofetil, MMF, CellCept®, mycophenolic acid, MPA, Continue IS (MTX), methotrexate, MTX, Continue IS (B cell depletion therapy), mAbs targeting CD19 or CD20, anti-BAFF mAb, Monovalent [B.1.351] CoV2 preS dTM-AS03, Sanofi-GSK COVID-19 Vaccine, Withhold IS (MMF or MPA), Withhold IS (MTX), Withhold IS (B cell depletion therapy), Moderna mRNA-1273, Bivalent, mRNA-1273 vaccine (Moderna), Bivalent, Moderna COVID-19 Vaccine, Bivalent, SARS-CoV-2 RNA vaccine, Bivalent, COVID-19 vaccine, Bivalent, BNT162b2, Bivalent, mRNA-1273 vaccine (Pfizer/BioNTech), Bivalent, Pfizer-BioNTech COVID-19 vaccine, Bivalent
National Institute of Allergy and Infectious Diseases (NIAID), Autoimmunity Centers of Excellence, Rho Federal Systems Division, Inc.
Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris, Multiple Sclerosis (MS), Systemic Sclerosis (SSc), Pediatric SLE, Juvenile Idiopathic Arthritis (JIA), Juvenile Dermatomyositis (JDM), Pediatric-Onset Multiple Sclerosis (POMS)
06/23
03/24
DIVERT, NCT05306873: Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

Terminated
2
9
US
Mycophenolate Mofetil, CellCept, MMF, Placebo for Mycophenolate Mofetil, Voclosporin, Lupkynis, Lupkynis(TM), Placebo for Voclosporin
National Institute of Allergy and Infectious Diseases (NIAID)
Systemic Lupus Erythematosus
04/24
04/24
VIBRANT, NCT05201469: VIB4920 for Active Lupus Nephritis

Recruiting
2
74
US
VIB4920, Placebo for VIB4920
National Institute of Allergy and Infectious Diseases (NIAID)
Lupus Nephritis
08/26
03/27
NCT06153095: A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)

Withdrawn
1/2
30
US, RoW
IMPT-514
Lyell Immunopharma, Inc.
Systemic Lupus Erythematosus, Lupus Nephritis
01/25
01/25

Download Options